The company said that envudeucitinib met all the primary and secondary endpoints in both trials. ・Across both trials, the ...
Alumis (ALMS) stock is soaring after the company announced positive trial results for its plaque psoriasis drug ...
Alumis Inc. ( ($ALMS) ) just unveiled an announcement. On January 6, 2026, Alumis reported positive topline Phase 3 results from its ONWARD1 and ...
Alumis Inc. (NASDAQ:ALMS) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 21, Alumis Inc. (NASDAQ:ALMS) reported that it has completed its merger with ACELYRIN, Inc. As part of this ...